We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMC
12201
PUT
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$97K ﹤0.01%
5,680
-3,100
-35% -$60.6K
AQST icon
12202
Aquestive Therapeutics
AQST
$575M
$96K ﹤0.01%
36,790
-61,078
-62% -$178K
DMAC icon
12203
DiaMedica Therapeutics
DMAC
$374M
$96K ﹤0.01%
38,232
-27,368
-42% -$77.6K
LSTA icon
12204
CALL
Lisata Therapeutics
LSTA
$11M
$96K ﹤0.01%
8,833
+1,833
+26% +$21K
OVID icon
12205
CALL
Ovid Therapeutics
OVID
$472M
$96K ﹤0.01%
30,700
-19,300
-39% -$60.7K
POET icon
12206
POET Technologies
POET
$1.46B
$96K ﹤0.01%
+13,288
New +$102K
ALPP
12207
DELISTED
Alpine 4 Holdings Inc
ALPP
$96K ﹤0.01%
11,381
-2,469
-18% -$30.2K
ENG
12208
CALL
DELISTED
ENGlobal Corp
ENG
$96K ﹤0.01%
9,275
-9,938
-52% -$96.9K
FTEV.WS
12209
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$96K ﹤0.01%
457,082
-35,722
-7% -$14.3K
MIC
12210
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$96K ﹤0.01%
25,685
+9,919
+63% +$36.3K
BRD.WS
12211
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$96K ﹤0.01%
+301,000
New +$113K
FRMM
12212
PUT
Forum Markets
FRMM
$80.4M
$95K ﹤0.01%
10
-2
-17% -$23K
HOOK
12213
DELISTED
HOOKIPA Pharma
HOOK
$95K ﹤0.01%
4,153
+125
+3% +$2.24K
KTTA icon
12214
Pasithea Therapeutics
KTTA
$15.9M
$95K ﹤0.01%
+3,647
New +$92.2K
PSNL icon
12215
CALL
Personalis
PSNL
$1.51B
$95K ﹤0.01%
11,600
-2,400
-17% -$24.8K
SMRT icon
12216
CALL
SmartRent
SMRT
$272M
$95K ﹤0.01%
18,700
-42,200
-69% -$304K
TLYS icon
12217
Tilly's
TLYS
$130M
$95K ﹤0.01%
10,160
-110,301
-92% -$1.36M
BSIN
12218
Big Sky Industrial
BSIN
$70.1M
$95K ﹤0.01%
21,909
-5,030
-19% -$21.7K
ABST
12219
CALL
DELISTED
Absolute Software Corp
ABST
$95K ﹤0.01%
+11,200
New +$94.9K
ASAP
12220
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$95K ﹤0.01%
12,775
-3,175
-20% -$32.9K
AXTI icon
12221
AXT Inc
AXTI
$4.84B
$94K ﹤0.01%
+13,456
New +$101K
CKPT
12222
CALL
DELISTED
Checkpoint Therapeutics
CKPT
$94K ﹤0.01%
5,290
-14,930
-74% -$321K
EOSE icon
12223
Eos Energy Enterprises
EOSE
$1.54B
$94K ﹤0.01%
+22,479
New +$92.6K
RCAT icon
12224
PUT
Red Cat Holdings
RCAT
$1.61B
$94K ﹤0.01%
46,700
-5,500
-11% -$10.6K
SPRO icon
12225
Spero Therapeutics
SPRO
$70.6M
$94K ﹤0.01%
+10,797
New +$111K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.